The future is now: Model-based clinical trial design for Alzheimer's disease-Reference-Cited by-同舟云学术

The future is now: Model-based clinical trial design for Alzheimer's disease

Published:2014-12-27 Issue:3 Volume:97 Page:210-214
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Romero K¹,Ito K²,Rogers JA³,Polhamus D³,Qiu R²,Stephenson D¹,Mohs R⁴,Lalonde R²,Sinha V⁵,Wang Y⁵,Brown D⁶,Isaac M⁶,Vamvakas S⁶,Hemmings R⁶,Pani L⁶,Bain LJ¹,Corrigan B²,

Affiliation:

1. Critical Path Institute; Tucson Arizona USA

2. Pfizer; Groton Connecticut USA

3. Metrum Research Group; Tariffville Connecticut USA

4. Eli Lilly; Lilly Corporate Center; Indianapolis Indiana USA

5. US Food and Drug Administration; Silver Spring Maryland USA

6. European Medicines Agency; London UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.16/fullpdf

Reference9 articles.

1. The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases;Romero;Clin. Pharmacol. Ther.,2009

2. Development of a unified clinical database for Alzheimer's disease;Neville;Alzheimer's Dement.,2015

3. Combining patient-level and summary-level data for Alzheimer's disease modeling and simulation: a beta regression meta-analysis;Rogers;J. Pharmacokinet. Pharmacodyn.,2012

4. An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative;Samtani;J. Clin. Pharmacol.,2012

5. Methodologic aspects of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine;Holford;Proc. Natl. Acad. Sci. USA.,1992

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention;Nutrition Journal;2024-06-12

2. New clinical trial design in precision medicine: discovery, development and direction;Signal Transduction and Targeted Therapy;2024-03-04

3. Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop;Neurotherapeutics;2023-10

4. Correction: Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop;Neurotherapeutics;2023-10

5. Feasibility Assessment of Using CDISC Data Standards for In Silico Medical Device Trials;Journal of the Society for Clinical Data Management;2023-09-21